Immunodeficiency in patients with non-Hodgkin lymphomas

Area of Science:

• Immunology
• Oncology
• Hematology

Background:

• Non-Hodgkin lymphomas (NHL) are a heterogeneous group of cancers affecting lymphocytes.
• Immune system dysfunction is often observed in lymphoma patients, but its extent varies with lymphoma type.
• Understanding immune status can provide insights into disease behavior and patient prognosis.

Purpose of the Study:

• To assess immune function in previously untreated patients with non-Hodgkin lymphomas.
• To correlate immune test results with lymphoma histology, stage, symptoms, and survival.
• To compare immune status between diffuse and nodular lymphoma subtypes.

Main Methods:

• Studied 71 untreated NHL patients using peripheral blood lymphocyte counts, serum immunoglobulin levels, and delayed hypersensitivity skin tests to six recall antigens.
• Classified lymphomas using Rappaport histology and Ann Arbor staging.
• Correlated immune function data with clinical parameters and survival outcomes.

Main Results:

• Patients with diffuse lymphomas exhibited significant impairment in skin test reactivity to five of six antigens.
• Diffuse histiocytic lymphoma was associated with lymphopenia and reduced serum IgA.
• Nodular lymphoma patients had normal lymphocyte counts but lower IgG and IgA, with impaired reactivity to two antigens.
• Survival was superior for patients with nodular lymphoma compared to diffuse lymphoma, and for symptom-free patients within the diffuse group.

Conclusions:

• Severe immunodeficiency characterizes diffuse non-Hodgkin lymphomas, especially diffuse histiocytic lymphoma.
• Nodular lymphoma is associated with less severe immune deficiencies.
• Immune function status is a significant prognostic factor in non-Hodgkin lymphoma patients.